ES2162551B1 - Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales. - Google Patents
Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales.Info
- Publication number
- ES2162551B1 ES2162551B1 ES9900741A ES9900741A ES2162551B1 ES 2162551 B1 ES2162551 B1 ES 2162551B1 ES 9900741 A ES9900741 A ES 9900741A ES 9900741 A ES9900741 A ES 9900741A ES 2162551 B1 ES2162551 B1 ES 2162551B1
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- tumor cells
- defective adenovirus
- selective replication
- replication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Procedimiento para la replicación selectiva de adenovirus defectivos en células tumorales, que consiste en el uso de adenovirus delecionados del gen E1B completo, tanto de la zona que codifica para la proteína de 55k y 19k, cualquiera que sea la vía de administración.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9900741A ES2162551B1 (es) | 1999-04-09 | 1999-04-09 | Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9900741A ES2162551B1 (es) | 1999-04-09 | 1999-04-09 | Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2162551A1 ES2162551A1 (es) | 2001-12-16 |
ES2162551B1 true ES2162551B1 (es) | 2002-07-01 |
Family
ID=8307984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9900741A Expired - Fee Related ES2162551B1 (es) | 1999-04-09 | 1999-04-09 | Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2162551B1 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5801029A (en) * | 1993-02-16 | 1998-09-01 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
FR2705686B1 (fr) * | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
US5858678A (en) * | 1994-08-02 | 1999-01-12 | St. Louis University | Apoptosis-regulating proteins |
US6403370B1 (en) * | 1997-02-10 | 2002-06-11 | Genstar Therapeutics Corporation | Oncolytic/immunogenic complementary-adenoviral vector system |
-
1999
- 1999-04-09 ES ES9900741A patent/ES2162551B1/es not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2162551A1 (es) | 2001-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1007537T3 (da) | Receptor-protein med betegnelsen 2F1 | |
DK1082410T3 (da) | Humane CD45 - og/eller fibroblast mesenchymale stamceller | |
TR200100056T2 (tr) | Nörotrofik faktörler | |
ATE310829T1 (de) | Zelllinien und konstrukte für die herstellung von e1-deletierten adenoviren in abwesenheit von replikationskompetentem adenovirus | |
TR200102308T2 (tr) | Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı | |
NO950939L (no) | Defektive adenovirusvektorer og deres anvendelse i gene-terapien | |
ATE540686T1 (de) | Adenovirus mit erhöhter infektiosität und konditionaler replikationsfähigkeit und deren verwendungen | |
ATE286139T1 (de) | Replikationskompetente anti-tumor vektoren | |
DE69820908D1 (de) | N-benzyl-3-indenylaceamidderivative zur behandlung von neoplasia | |
NO20011132D0 (no) | FremgangsmÕte til Õ innføre apoptosis i kreftceller | |
IT1317835B1 (it) | Citochine modificate per uso nella terapia del cancro. | |
UY27192A1 (es) | Inhibidores de peptido-deformilasa | |
DE69926251D1 (de) | Verfahren zum vernichten von tumoren und tumor-assoziierten endothelialzellen mit adenoviralen mutanten | |
ES2162551B1 (es) | Procedimiento para la replicacion selectiva de adenovirus defectivos en celulas tumorales. | |
PL376573A1 (pl) | Nowe adenowirusy, kodujące je kwasy nukleinowe i ich zastosowanie | |
DK1144666T3 (da) | Replikationsdeficient baculovirusekspressionssystem | |
ATE431742T1 (de) | Modifizierte zytokine für krebs therapie | |
ES2183752T1 (es) | Vectores adenovirales recombinantes y su utilizacion en el tratamiento de distintos tipos de la fibrosis hepatica, renal y pulmonar y cicatrices hipertroficas. | |
DE69828791D1 (de) | Das antigen ha-1 | |
DK1224310T3 (da) | Fremstilling af rekombinante adenovira og adenovirale banker | |
NO986035D0 (no) | Kombinasjoner omfattende VX478, zidovudin og/eller 1592U89 for anvendelse i | |
TR199802387T2 (xx) | Do�um kontrol� i�in kullan�lan Zona Pellucida proteinleri. | |
FR2811682A3 (fr) | Utilisation du dextran marque pour la detection de la permeabilisation de la membrane plasmique ou la mort cellulaire | |
ITIM980003A0 (it) | Sistema per la creazione di terreni galleggianti, mobili e coltivabili | |
EP0843006A3 (en) | Recombinant PSA expression vectors and assays using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20011216 Kind code of ref document: A1 Effective date: 20011216 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20190726 |